Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Quince Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · South San Francisco, CA, United States

  1. PrincipalsBrendan HannahCBO, COO & CCOCharles S. RyanPresidentDirk ThyeCEO and CMOand 5 more
  2. CompanyQuince Therapeutics, Inc.South San Francisco, CA, United States
  3. Phone line+1 (415) 910-5717General business
Request a quote

Quince Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker QNCX) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 8

Chief executive

Dirk ThyeCEO and CMO

Chair & board

Christopher J. SennerDirector (Board)
David LamondDirector (Board)
June BrayDirector (Board)
Luca BenattiDirector (Board)

Operations

Brendan HannahCBO, COO & CCO

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Christopher J. Senner — Director (Board)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers